Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+7.12%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$35.8B
Cap. Flow
% of AUM
-178.2%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$78.3M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$69.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$67.8M |
| 4 |
SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$51.6M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$49.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Microsoft
MSFT
|
+$2.03B |
| 3 |
Apple
AAPL
|
+$1.62B |
| 4 |
Amazon
AMZN
|
+$1.15B |
| 5 |
Meta Platforms (Facebook)
META
|
+$886M |
Sector Composition
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Essential Utilities
WTRG
$10.6B
| $233K | ﹤0.01% |
6,239
-13,095
| -68% | -$490K |
|
1027
Roivant Sciences
ROIV
$9.4B
| $233K | ﹤0.01% |
22,055
-27,807
| -56% | -$294K |
|
1028
Annaly Capital Management
NLY
$14.2B
| $232K | ﹤0.01% |
11,811
-1,021,798
| -99% | -$20.1M |
|
1029
PROS Holdings
PRO
$727M
| $232K | ﹤0.01% |
8,120
-399,561
| -98% | -$11.4M |
|
1030
iShares Global Infrastructure ETF
IGF
$8.2B
| $231K | ﹤0.01% |
50,993
-69,517
| -58% | -$315K |
|
1031
Jazz Pharmaceuticals
JAZZ
$7.7B
| $230K | ﹤0.01% |
2,151
-72,808
| -97% | -$7.8M |
|
1032
Fomento Económico Mexicano
FMX
$30.1B
| $228K | ﹤0.01% |
+2,147
| New | +$228K |
|
1033
PubMatic
PUBM
$370M
| $228K | ﹤0.01% |
11,621
-401,324
| -97% | -$7.86M |
|
1034
iShares US Real Estate ETF
IYR
$3.66B
| $227K | ﹤0.01% |
+2,610
| New | +$227K |
|
1035
NNN REIT
NNN
$8.06B
| $224K | ﹤0.01% |
+5,305
| New | +$224K |
|
1036
Appian
APPN
$2.3B
| $224K | ﹤0.01% |
7,333
-359,636
| -98% | -$11M |
|
|
ITCI
1037
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $224K | ﹤0.01% |
3,152
-40,602
| -93% | -$2.88M |
|
|
PARA
1038
DELISTED
Paramount Global Class B
PARA
| $223K | ﹤0.01% |
21,687
-91,664
| -81% | -$940K |
|
1039
OneSpan
OSPN
$578M
| $215K | ﹤0.01% |
16,718
-1,162,850
| -99% | -$15M |
|
|
CNH
1040
CNH Industrial
CNH
$14.1B
| $210K | ﹤0.01% |
+20,634
| New | +$210K |
|
1041
Stellantis
STLA
$27.6B
| $209K | ﹤0.01% |
+10,565
| New | +$209K |
|
1042
BRF SA
BRFS
$5.99B
| $208K | ﹤0.01% |
51,721
-11,648
| -18% | -$46.8K |
|
1043
Omnicell
OMCL
$1.46B
| $208K | ﹤0.01% |
7,900
-553,632
| -99% | -$14.5M |
|
1044
Ionis Pharmaceuticals
IONS
$10.2B
| $206K | ﹤0.01% |
4,358
-10,723
| -71% | -$506K |
|
1045
CEMIG Preferred Shares
CIG
$5.81B
| $205K | ﹤0.01% |
112,629
-34,249
| -23% | -$62.3K |
|
|
BPMC
1046
DELISTED
Blueprint Medicines
BPMC
| $203K | ﹤0.01% |
1,869
-32,663
| -95% | -$3.54M |
|
1047
Innovative Industrial Properties
IIPR
$1.58B
| $199K | ﹤0.01% |
1,812
-203,347
| -99% | -$22.4M |
|
1048
Brixmor Property Group
BRX
$8.51B
| $198K | ﹤0.01% |
8,678
-6,381
| -42% | -$145K |
|
1049
Halozyme
HALO
$8.87B
| $196K | ﹤0.01% |
3,800
-74,864
| -95% | -$3.87M |
|
1050
Exelixis
EXEL
$10.1B
| $196K | ﹤0.01% |
8,697
-27,074
| -76% | -$610K |
|